Cargando…
Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221028/ http://dx.doi.org/10.1186/1471-2334-14-S2-P84 |
_version_ | 1782342833537024000 |
---|---|
author | Ménard, A Dhiver, C Ravaux, I Moreau, J Mokhtari, S Colson, P Meddeb, L Brouqui, P Stein, A |
author_facet | Ménard, A Dhiver, C Ravaux, I Moreau, J Mokhtari, S Colson, P Meddeb, L Brouqui, P Stein, A |
author_sort | Ménard, A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4221028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42210282014-11-10 Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients Ménard, A Dhiver, C Ravaux, I Moreau, J Mokhtari, S Colson, P Meddeb, L Brouqui, P Stein, A BMC Infect Dis Poster Presentation BioMed Central 2014-05-23 /pmc/articles/PMC4221028/ http://dx.doi.org/10.1186/1471-2334-14-S2-P84 Text en Copyright © 2014 Ménard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Ménard, A Dhiver, C Ravaux, I Moreau, J Mokhtari, S Colson, P Meddeb, L Brouqui, P Stein, A Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title | Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title_full | Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title_fullStr | Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title_full_unstemmed | Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title_short | Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients |
title_sort | efficacy and safety of hepatitis c direct-acting protease inhibitors (daa-pi ) in real life in hiv-hcv coinfected patients |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221028/ http://dx.doi.org/10.1186/1471-2334-14-S2-P84 |
work_keys_str_mv | AT menarda efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT dhiverc efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT ravauxi efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT moreauj efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT mokhtaris efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT colsonp efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT meddebl efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT brouquip efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients AT steina efficacyandsafetyofhepatitiscdirectactingproteaseinhibitorsdaapiinreallifeinhivhcvcoinfectedpatients |